TABLE 3.
Unadjusted and adjusted outcomes in patients treated with CST or CST-MINa
| Parameterb | Value for patients treated with: |
OR (95% CI) | P valuec | C statistic | |
|---|---|---|---|---|---|
| CST | CST-MIN | ||||
| Unadjusted outcomes, % of patients | n = 4,817 | n = 93 | |||
| ARF | 23.7 | 11.8 | 0.431 (0.229, 0.812) | 0.007 | |
| Mortality | 29.5 | 31.2 | 1.081 (0.694, 1.683) | 0.731 | |
| 30-day readmission | 26.6 | 31.3 | 1.256 (0.736, 2.142) | 0.402 | |
| PSM (1:8 matching), % of patients | n = 664 | n = 83 | |||
| ARF | 22.3 | 12.0 | 0.478 (0.241, 0.948) | 0.031 | |
| Mortality | 28.9 | 32.5 | 1.185 (0.727, 1.933) | 0.495 | |
| 30-day readmission | 29.9 | 30.4 | 1.023 (0.560, 1.870) | 0.940 | |
| Logistic regression model | n = 4,817 | n = 93 | |||
| ARF | 0.403 (0.211, 0.770) | 0.006 | 0.673 | ||
| Mortality | 1.031 (0.642, 1.656) | 0.898 | 0.714 | ||
| 30-day readmission | 1.139 (0.664, 1.954) | 0.636 | 0.577 | ||
a
Abbreviations: PSM, propensity score matching; OR, odds ratio; CI, confidence interval; ARF, acute renal failure.
b
Thirty-day readmission was estimated based on the patients who survived from index hospitalization.
c
P values in bold indicate a significance difference.